Study: NCT02123615

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 36
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subdermally at Week 12

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subdermally at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subdermally at Week 12